LES005.3.09B-Renovia-Agreement-30Oct18-FINAL
Recent Press Releases
- Renovia Appoints John A. Fallon, M.D. to its Board of Directors
- Renovia Launches “REDUCE” – a Multi-Center Randomized Controlled Trial to Study Next-Generation leva® Pelvic Digital Therapeutic System for Urinary Incontinence
- Renovia Appoints Tara Butler, M.D. to its Board of Directors
- Renovia Appoints Dan Levangie to its Board of Directors
- Renovia Supports ACOG and WPSI Recommendations Related to Screening for Urinary Incontinence
- Renovia Completes $42.3 Million Series B Financing